Healthcare Triangle is trading 6.72% higher at $0.39; its October 20 announcement of six new AI contracts targeting approximately $4.65 million in annual run-rate revenue is the clearest potential company-specific catalyst.
- The announcement does not explicitly say it caused the share-price move.
- The October 1 Nasdaq delisting determination is older context, not a new catalyst for this session.
- Provided market context is mixed and does not establish a broader-market explanation.